BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38452275)

  • 1. Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems.
    Liu N; Lin Q; Huang Z; Liu C; Qin J; Yu Y; Chen W; Zhang J; Jiang M; Gao X; Huo S; Zhu X
    ACS Nano; 2024 Mar; 18(11):7945-7958. PubMed ID: 38452275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
    Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
    Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer.
    Zhou TJ; Zhang MM; Liu DM; Huang LL; Yu HQ; Wang Y; Xing L; Jiang HL
    Biomaterials; 2024 Mar; 305():122447. PubMed ID: 38154441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration.
    Clemente LP; Rabenau M; Tang S; Stanka J; Cors E; Stroh J; Culmsee C; von Karstedt S
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase.
    Zhang S; Kang L; Dai X; Chen J; Chen Z; Wang M; Jiang H; Wang X; Bu S; Liu X; Zhang G; Tang H
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):202-212. PubMed ID: 36228830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring Mitochondria Function in Ferroptosis.
    Chen F; Liu J; Tang D; Kang R
    Methods Mol Biol; 2023; 2712():103-115. PubMed ID: 37578700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis.
    Jelinek A; Heyder L; Daude M; Plessner M; Krippner S; Grosse R; Diederich WE; Culmsee C
    Free Radic Biol Med; 2018 Mar; 117():45-57. PubMed ID: 29378335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.
    Hai Y; Fan R; Zhao T; Lin R; Zhuang J; Deng A; Meng S; Hou Z; Wei G
    Pharmacol Res; 2024 Apr; 202():107115. PubMed ID: 38423231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria.
    Wu S; Mao C; Kondiparthi L; Poyurovsky MV; Olszewski K; Gan B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(26):e2121987119. PubMed ID: 35749365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diversified role of mitochondria in ferroptosis in cancer.
    Liu Y; Lu S; Wu LL; Yang L; Yang L; Wang J
    Cell Death Dis; 2023 Aug; 14(8):519. PubMed ID: 37580393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy.
    Yao L; Yang N; Zhou W; Akhtar MH; Zhou W; Liu C; Song S; Li Y; Han W; Yu C
    Adv Healthc Mater; 2023 Oct; 12(26):e2300871. PubMed ID: 37204046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Warburg effect modulates DHODH role in ferroptosis: a review.
    Amos A; Amos A; Wu L; Xia H
    Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System.
    Chen S; Yang J; Liang Z; Li Z; Xiong W; Fan Q; Shen Z; Liu J; Xu Y
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2705-2713. PubMed ID: 36622364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
    Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ROS-Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis Therapy.
    Zhang Y; Li L; Li Y; Fei Y; Xue C; Yao X; Zhao Y; Wang X; Li M; Luo Z
    Adv Healthc Mater; 2022 Jan; 11(2):e2101702. PubMed ID: 34710950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled thioether-bridged paclitaxel-dihydroartemisinin prodrug for amplified antitumor efficacy-based cancer ferroptotic-chemotherapy.
    Zheng Y; Qin C; Li F; Qi J; Chu X; Li H; Shi T; Yan Z; Yang L; Xin X; Liu L; Han X; Yin L
    Biomater Sci; 2023 May; 11(9):3321-3334. PubMed ID: 36946490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease.
    Xie LH; Fefelova N; Pamarthi SH; Gwathmey JK
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mitochondria-Targeted Ferroptosis Inducer Activated by Glutathione-Responsive Imaging and Depletion for Triple Negative Breast Cancer Theranostics.
    Gan H; Huang X; Luo X; Li J; Mo B; Cheng L; Shu Q; Du Z; Tang H; Sun W; Wang L; Luo S; Yu S
    Adv Healthc Mater; 2023 Sep; 12(22):e2300220. PubMed ID: 37204240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Lipid Peroxidation Is Responsible for Ferroptosis.
    Lyamzaev KG; Panteleeva AA; Simonyan RA; Avetisyan AV; Chernyak BV
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroorotate dehydrogenase regulates ferroptosis in neurons after spinal cord injury via the P53-ALOX15 signaling pathway.
    Li D; Lu X; Xu G; Liu S; Gong Z; Lu F; Xia X; Jiang J; Wang H; Zou F; Ma X
    CNS Neurosci Ther; 2023 Jul; 29(7):1923-1939. PubMed ID: 36942513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.